A phase 3, multicenter, randomized, double-blind, comparative study to evaluate the safety and efficacy of ceftaroline [ceftaroline fosamil] versus ceftriaxone in the treatment of adult subjects with community-acquired pneumonia.

Trial Profile

A phase 3, multicenter, randomized, double-blind, comparative study to evaluate the safety and efficacy of ceftaroline [ceftaroline fosamil] versus ceftriaxone in the treatment of adult subjects with community-acquired pneumonia.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Ceftaroline fosamil (Primary) ; Ceftriaxone
  • Indications Community-acquired pneumonia; Staphylococcal infections; Streptococcal infections
  • Focus Registrational; Therapeutic Use
  • Acronyms FOCUS-2; FOCUS-II
  • Sponsors Cerexa; Forest Laboratories
  • Most Recent Events

    • 05 Jun 2017 Results of subgroup analysis from two phase III studies (FOCUS-1 and FOCUS-2) presented at the ASM Microbe 2017.
    • 12 Apr 2016 Results from CANVAS-1, CANVAS 2, COVERS, FOCUS 1, FOCUS 2 and Asia CAP trials (n=4055) presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
    • 28 Apr 2012 Planned number of patients changed from 550 to 626 as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top